HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shufeng Chen Selected Research

Hypertension (High Blood Pressure)

12/2021Study design, general characteristics of participants, and preliminary findings from the metabolome, microbiome, and dietary salt intervention study (MetaSalt).
1/2018Associations of NADPH oxidase-related genes with blood pressure changes and incident hypertension: The GenSalt Study.
1/2017Associations of the Serum/Glucocorticoid Regulated Kinase Genes With BP Changes and Hypertension Incidence: The Gensalt Study.
11/2016Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study.
10/2015Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese.
10/2014Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population.
5/2014Multivariate meta-analysis of the association of G-protein beta 3 gene (GNB3) haplotypes with cardiovascular phenotypes.
5/2014Short leukocyte telomere length is associated with obesity in American Indians: the Strong Heart Family study.
1/2014Association study of common variations of FBN1 gene and essential hypertension in Han Chinese population.
8/2012Association between genetic variants of the ADD1 and GNB3 genes and blood pressure response to the cold pressor test in a Chinese Han population: the GenSalt Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shufeng Chen Research Topics

Disease

17Hypertension (High Blood Pressure)
12/2021 - 11/2004
10Essential Hypertension
01/2013 - 11/2004
9Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 11/2006
6Coronary Artery Disease (Coronary Atherosclerosis)
02/2022 - 12/2017
6Coronary Disease (Coronary Heart Disease)
01/2020 - 04/2006
4Atherosclerosis
02/2022 - 02/2009
3Myocardial Infarction
01/2018 - 11/2006
3Type 2 Diabetes Mellitus (MODY)
01/2015 - 11/2004
2Obesity
10/2021 - 11/2004
2Overweight
10/2021 - 05/2014
2Genetic Risk Score
12/2018 - 02/2016
1Atherosclerotic Plaque (Atheroma)
02/2022
1Heart Diseases (Heart Disease)
12/2021
1COVID-19
06/2021
1Neointima
01/2021
1Lung Neoplasms (Lung Cancer)
12/2020
1Abdominal Obesity
01/2018
1Hyperlipidemias (Hyperlipidemia)
02/2016
1Genetic Predisposition to Disease (Genetic Predisposition)
02/2016
1Unstable Angina
01/2015
1Acute Coronary Syndrome
01/2015
1Vascular Remodeling
01/2014
1Inflammation (Inflammations)
07/2009
1Tuberculosis (Tuberculoses)
07/2008

Drug/Important Bio-Agent (IBA)

5Particulate MatterIBA
10/2021 - 01/2020
4LipidsIBA
12/2021 - 11/2004
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
08/2012 - 12/2010
2SodiumIBA
12/2021 - 12/2018
2SaltsIBA
12/2021 - 01/2018
2Antihypertensive Agents (Antihypertensives)IBA
11/2021 - 01/2014
2Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2018
2Long Noncoding RNAIBA
01/2019 - 01/2018
2C-Reactive ProteinIBA
05/2014 - 07/2009
2Fibrillin-1IBA
01/2014 - 06/2011
1CytokinesIBA
02/2022
1MicroRNAs (MicroRNA)IBA
02/2022
1CholesterolIBA
02/2022
1Biological ProductsIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1LDL CholesterolIBA
12/2021
1VaccinesIBA
06/2021
1N-methyladenosineIBA
01/2021
16-methyladenineIBA
01/2021
1Circular RNAIBA
01/2019
1Triglycerides (Triacylglycerol)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2018
1HDL CholesterolIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1serum-glucocorticoid regulated kinaseIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1GlucocorticoidsIBA
01/2017
1Calcium Channels (Calcium Channel)IBA
11/2016
1Apolipoproteins E (ApoE)IBA
02/2016
1Genetic Markers (Genetic Marker)IBA
10/2015
1Messenger RNA (mRNA)IBA
01/2015
1Sirtuin 1IBA
01/2015
1Transforming Growth Factor-beta Type II ReceptorIBA
10/2014
1GTP-Binding Proteins (G-Protein)IBA
05/2014
1AdrenomedullinIBA
01/2013
1Factor VII (Proconvertin)IBA
08/2011
1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA
02/2011
1Transforming Growth Factor beta (TGF-beta)IBA
11/2009
1Kininogens (Kininogen)IBA
03/2009
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
02/2009
1EnzymesIBA
09/2008
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
09/2008
1CatecholaminesIBA
09/2008
1vasectrin II (VS II)IBA
06/2008
1Tissue Kallikreins (Tissue Kallikrein)IBA
09/2007
1DNA (Deoxyribonucleic Acid)IBA
09/2007
1renalaseIBA
08/2007
1Plasma KallikreinIBA
05/2007
1Peptides (Polypeptides)IBA
05/2007
1KininsIBA
05/2007
1Serine Proteases (Serine Protease)IBA
05/2007
1Proteins (Proteins, Gene)FDA Link
11/2006
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2006
1G-Protein-Coupled Receptor Kinase 4IBA
11/2006
1Adrenergic Receptors (Adrenergic Receptor)IBA
06/2006
1Plasminogen Activators (Plasminogen Activator)IBA
04/2006
1PPAR gammaIBA
11/2004

Therapy/Procedure

2Therapeutics
11/2021 - 07/2008